HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Type G-Cockayne Syndrome Xeroderma Pigmentosum

Also Known As:

Xeroderma Pigmentosum, Type G-Cockayne Syndrome; Xpg-Cs

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Musculoskeletal Diseases: 719
- Bone Diseases: 5863
  - Developmental Bone Diseases: 153
    - Dwarfism: 1191
      - Cockayne Syndrome: 470
        Type G-Cockayne Syndrome Xeroderma Pigmentosum: 1
Nervous System Diseases: 14178
- Neurodegenerative Diseases: 42472
  - Nervous System Heredodegenerative Disorders: 63
    - Cockayne Syndrome: 470
      - Type G-Cockayne Syndrome Xeroderma Pigmentosum: 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Congenital Abnormalities: 25723
  - Multiple Abnormalities: 211
    - Cockayne Syndrome: 470
      - Type G-Cockayne Syndrome Xeroderma Pigmentosum: 1
  - Skin Abnormalities: 159
    - Xeroderma Pigmentosum: 1866
      - Type G-Cockayne Syndrome Xeroderma Pigmentosum: 1
- Inborn Genetic Diseases: 11939
Nutritional and Metabolic Diseases: 15
- Metabolic Diseases: 10142
  - DNA Repair-Deficiency Disorders: 538
    - Xeroderma Pigmentosum: 1866
      - Type G-Cockayne Syndrome Xeroderma Pigmentosum: 1
    - Cockayne Syndrome: 470
      - Type G-Cockayne Syndrome Xeroderma Pigmentosum: 1
Neoplasms: 1324753
- Precancerous Conditions: 304
  - Xeroderma Pigmentosum: 1866
    - Type G-Cockayne Syndrome Xeroderma Pigmentosum: 1
Skin and Connective Tissue Diseases
- Skin Diseases: 13127

Experts

1.	Harada, Yoshi-Nobu: 1 article (05/2004)
2.	Ikawa, Masahito: 1 article (05/2004)
3.	Kito, Seiji: 1 article (05/2004)
4.	Matsunaga, Tsukasa: 1 article (05/2004)
5.	Okabe, Masaru: 1 article (05/2004)
6.	Oyama, Masaki: 1 article (05/2004)
7.	Shiomi, Naoko: 1 article (05/2004)
8.	Shiomi, Tadahiro: 1 article (05/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Type G-Cockayne Syndrome Xeroderma Pigmentosum:

1.	Codon (Codons)IBA 05/01/2004 - "To test the hypothesis that the CS phenotype, with characteristics such as growth retardation and a short life span in XPG/CS patients, results from C-terminal truncations, we constructed mutants with C-terminal truncations in mouse XPG (Xpg) (from residue D811 to the stop codon [XpgD811stop] and deletion of exon 15 [Xpg Delta ex15]). "